initiatives

Novartis Us Covid-19 Initiatives Novartis United States Of America

So actually fantastic trajectory here and an opportunity for us now to also accelerate our efforts outdoors of the United States to bring this medicine to a lot more numerous sclerosis patients around the world. Now with Leqvio, as we’ve noted, this is a steady build more than the course of 2023 and the very first half of 2024. Last quarter, we highlighted that we have good information or superior positioning ideal now with respect to market access with 70% of lives covered at or close to the full label. Otherwise, I assume there could surely be spillover from —...